| 0.4962 0.047 (10.54%) | 11-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.92 | 1-year : | 9.34 |
| Resists | First : | 5.07 | Second : | 8 |
| Pivot price | 0 | |||
| Supports | First : | 0.33 | Second : | 0.27 |
| MAs | MA(5) : | 0.43  |
MA(20) : | 0 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0 | Signal : | 0 |
| %K %D | K(14,3) : | 0 | D(3) : | 0 |
| RSI | RSI(14): 0 | |||
| 52-week | High : | 2.23 | Low : | 0.33 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MEHA ] has closed Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 0.51 - 0.51 | 0.51 - 0.51 |
| Low: | 0.38 - 0.38 | 0.38 - 0.38 |
| Close: | 0.49 - 0.5 | 0.5 - 0.5 |
The company manufactures and distributes nutraceutical supplements in the U.S., covering categories such as pain, energy, prenatal, general health, bone & joint, gastro, immunity, cardiac, detox, brain & memory, sleep, and urinary. It also offers hemp-derived products including capsules, gummies and tinctures.
Mon, 10 Nov 2025
Functional Brands partners with MPG to expand Kirkman brand By Investing.com - Investing.com Nigeria
Mon, 10 Nov 2025
Functional Brands (NASDAQ: MEHA) teams with MPG to scale Kirkman in eCommerce and retail - Stock Titan
Fri, 07 Nov 2025
S&P 500, NASDAQ and Dow Jones fall: Wall Street ends negative, check top gainers and losers of November 6; - The Economic Times
Thu, 06 Nov 2025
Functional Brands closes $8 million private placement and completes Nasdaq listing - Investing.com
Wed, 05 Nov 2025
Functional Brands (NASDAQ: MEHA) begins trading today following Nasdaq direct listing - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 7 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 12.6 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -0.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.03 |
| Profit Margin | -14.2 % |
| Operating Margin | -8.5 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 3.7 % |
| Gross Profit (p.s.) | 0.51 |
| Sales Per Share | 0.92 |
| EBITDA (p.s.) | -0.07 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -3.82 |
| PEG Ratio | 0 |
| Price to Book value | 12.4 |
| Price to Sales | 0.53 |
| Price to Cash Flow | 5.4 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|